Cargando…
Comorbidities and Metabolic Derangement of NAFLD
Nonalcoholic fatty liver disease (NAFLD) is an increasingly common cause of chronic liver disease worldwide and is becoming a major public health problem. NAFLD has been recognized as a hepatic manifestation of metabolic syndrome linked with insulin resistance. Growing evidence supports that NAFLD i...
Autores principales: | Bang, Ki Bae, Cho, Yong Kyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Yonsei University Wonju College of Medicine
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608226/ https://www.ncbi.nlm.nih.gov/pubmed/26528424 http://dx.doi.org/10.15280/jlm.2015.5.1.7 |
Ejemplares similares
-
Deranged Tyrosine Metabolism in Cirrhosis
por: Fulenwider, J. Timothy, et al.
Publicado: (1978) -
NAFLD or comorbidities, that is the question
por: Ponziani, Francesca Romana, et al.
Publicado: (2020) -
NAFLD and Extra-Hepatic Comorbidities: Current Evidence on a Multi-Organ Metabolic Syndrome
por: Rosato, Valerio, et al.
Publicado: (2019) -
Organelle Stress and Metabolic Derangement in Kidney Disease
por: Inagi, Reiko
Publicado: (2022) -
Reply to: ‘NAFLD or comorbidities, that is the question’
por: Ji, Dong, et al.
Publicado: (2020)